Matthew Hewitt

Stock Analyst at Craig-Hallum

(2.77)
# 1,789
Out of 5,008 analysts
3
Total ratings
66.67%
Success rate
27.26%
Average return

Stocks Rated by Matthew Hewitt

Certara
Sep 29, 2025
Initiates: Buy
Price Target: $16
Current: $12.93
Upside: +23.74%
Lifecore Biomedical
Nov 22, 2024
Maintains: Buy
Price Target: $8$10
Current: $6.75
Upside: +48.15%